Role of interleukin 6 in a murine model of Crohn's ileitis: are cytokine/anticytokine strategies the future for IBD therapies?
about
The immunobiology of colitis and cholangitis in interleukin-23p19 and interleukin-17A deleted dominant negative form of transforming growth factor beta receptor type II miceInvolvement of a Stat3 binding site in inflammation-induced enteric apelin expression.Effect of Cyperus Rotundus on Cytokine Gene Expression in Experimental Inflammatory Bowel Disease.Adenosine A2A receptor contributes to the anti-inflammatory effect of the fixed herbal combination STW 5 (Iberogast®) in rat small intestinal preparations.
P2860
Role of interleukin 6 in a murine model of Crohn's ileitis: are cytokine/anticytokine strategies the future for IBD therapies?
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Role of interleukin 6 in a mur ...... the future for IBD therapies?
@ast
Role of interleukin 6 in a mur ...... the future for IBD therapies?
@en
type
label
Role of interleukin 6 in a mur ...... the future for IBD therapies?
@ast
Role of interleukin 6 in a mur ...... the future for IBD therapies?
@en
prefLabel
Role of interleukin 6 in a mur ...... the future for IBD therapies?
@ast
Role of interleukin 6 in a mur ...... the future for IBD therapies?
@en
P2093
P2860
P356
P1433
P1476
Role of interleukin 6 in a mur ...... the future for IBD therapies?
@en
P2093
Cominelli F
De La Rue SA
Pizarro TT
P2860
P304
P356
10.1136/GUT.2005.083121
P407
P577
2006-09-01T00:00:00Z